SumeetBhanvadia Profile Banner
Sumeet Bhanvadia Profile
Sumeet Bhanvadia

@SumeetBhanvadia

Followers
652
Following
1K
Media
8
Statuses
147

urologic cancer surgeon, Sr. Medical Director-Bladder Cancer @JanssenUS, mom, wife, circumstantial vegan, not in that order

Los Angeles, CA
Joined March 2016
Don't wanna be here? Send us removal request.
@LoebStacy
Stacy Loeb, MD
2 years
Personal and Planetary Health—The Connection With Dietary Choices - hot off the press in @JAMA_current (Spoiler alert: whole food plant based diets are better for both!) 🌱🥗🌎 https://t.co/8DS5G2kVdq HT @UrviShahMD @DrGiaMerlo
3
6
40
@neerajaiims
Neeraj Agarwal, MD, FASCO
2 years
Breaking news from #AUA23 @AmerUrological : @siadaneshmand presents 1st results from SunRISE-1 trial 👉TAR-200 (local gemcitabine delivery system in bladder) in BCG refractory high-risk non-muscle invasive #bladdercancer 👉 amazing ~73% complete response 👇@OncoAlert @urotoday
8
81
227
@SWilliams_MD
Stephen B. Williams, MD, MBA, MS, FACHE
2 years
SunRISe-1 @siadaneshmand #AUA23 safety efficacy data up to 73% CR up to 11mo for bcg unresponsive nmibc! 💪 exciting results minimal toxicity! 🥨 @JanssenGlobal
1
6
29
@raveensyan
Raveen Syan, MD, FPMRS
4 years
Thank you @urotoday for highlighting our work looking at how a navigator can improve 3rd line treatment rates!
@urotoday
UroToday.com
4 years
Identifying navigator impact on utilization of onabotulinumtoxina as a 3rd line treatment in #OveractiveBladder: a retrospective database study in the #UnitedStates #SUFU22 > https://t.co/JIWNXrf8I9 @raveensyan @DrDianeNewman @NityaAbraham @DrEnemchukwu @sufuorg
0
5
17
@SumeetBhanvadia
Sumeet Bhanvadia
4 years
Committed and persistent work by @APMitra and @siadaneshmand highlighting post-cystectomy outcomes in which we’re improving, but also those that unfortunately have stayed the same. Hopefully can steer and support the need for exciting ongoing research like that of @montypal
@montypal
Sumanta K. Pal, MD, FASCO
4 years
No small feat to summarize this massive experience in #cystectomy from my colleagues at @USC_Urology. Terrific work from @siadaneshmand's group (@APMitra @SumeetBhanvadia @Hoomandjaladat et al) that underscores need to do more post-cystectomy to prevent relapse (eg #PROOF302, IO)
0
1
16
@montypal
Sumanta K. Pal, MD, FASCO
4 years
No small feat to summarize this massive experience in #cystectomy from my colleagues at @USC_Urology. Terrific work from @siadaneshmand's group (@APMitra @SumeetBhanvadia @Hoomandjaladat et al) that underscores need to do more post-cystectomy to prevent relapse (eg #PROOF302, IO)
1
8
37
@raveensyan
Raveen Syan, MD, FPMRS
4 years
Let’s start dropping the “y” and calling women what they are: bosses!
@AjvictoryMD
Amani Jambhekar MD, MBA, FACS
4 years
An attending called me “bossy” and “talks too much” but then also requested I be on his service as a PGY3 because he knew I would take care of his patients and he didn’t trust the PGY4 OR 5. No doubt if I’d been a male resident he would just have said I was a good leader.
1
1
15
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺
4 years
🚀🦾Huge congratulation to our @USC_Urology Chair Dr. Inderbir Gill for the @AmerUrological Presidential Citation for scientific innovations in robotic and laparoscopic oncologic surgery @AmerUrological @JUrology @KeckMedUSC @Uroweb @Urology_AI
1
9
61
@APMitra
Anirban Mitra
4 years
🙏🏽 Collaborative work with my alma mater @USC_Urology reporting on historic and contemporary outcomes after radical cystectomy @siadaneshmand @AnneSchuckmanMD @Hoomandjaladat @SumeetBhanvadia
@saumyg
Saum Ghodoussipour
4 years
Great work by my friend @APMitra! Despite increased use of NAC, RFS remains stagnant but OS has improved. Need better predictors of response #bladdercancer #SUO21 @SUO_YUO @USC_Urology
2
5
28
@hilmoss
Hil Moss
4 years
An incredibly important thread on #cancersurvivorship and #financialtoxicity
0
2
2
@SumeetBhanvadia
Sumeet Bhanvadia
4 years
Excited to be part of such an awesome team and doing this important work! @USC_Urology
@Testiscancer
Craig Nichols
4 years
Our GCT armada! USC-@siadaneshmand, @SumeetBhanvadia D'Sousa, @SanamLadi UCSD @AdityaBagrodia Millard BCC @LuciaNappi4 @MSoleimani_MD Kollmannsberger IU @nabiladra Masterson Cary USU-Kern Chestnut Madigan- Speir Much input Harzstark @KPNC @UTSW @SupportingSWOG for the launch
1
0
7
@neerajaiims
Neeraj Agarwal, MD, FASCO
4 years
#ASCO21 @ASCO Plenary #LBA5 : Keynote-564 trial results just out 👉 https://t.co/WCotnsOJHK ,in patients with high risk resected #kidneycancer: Pembrolizumab significantly improves disease free survival. Practice changing data Congrats @DrChoueiri @tompowles1 @OncoAlert
10
108
202
@lauramakaroff
Laura Makaroff
4 years
Great slide @drfolamay! We must continue to address upstream factors to end disparities in cancer screening and care. #healthequity #ASCO2021 @NCCRTnews @ACSNews
1
10
27
@uroegg
Scott Eggener
4 years
More data suggesting access and quality supersedes race-based biology in PrCa. cc: @BrandonMahal @DrSpratticus @DrAdamMurphy Association of Health-Care System with Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men
Tweet card summary image
academic.oup.com
AbstractBackground. Disparities in prostate cancer-specific mortality (PCSM) between African American and non-Hispanic White (White) patients have been att
1
12
42
@SumeetBhanvadia
Sumeet Bhanvadia
4 years
Such a pleasure to have been invited to virtually sit down with this stellar group!
@dsui_miami_uro
Desai Sethi Urology Institute
4 years
Thanks to @syan_sumeet for comprehensive grand rounds this morning @miami_urology on new options and dilemmas in bladder cancer! @USC_Urology @KeckMedUSC @raveensyan @umiamimedicine @SUO_YUO
0
2
14
@SumeetBhanvadia
Sumeet Bhanvadia
5 years
Proud to have worked with several of these @USC_Urology — congrats to all! @GerhardFuchs9 @GU_BigWhacks @isurujay
@saumyg
Saum Ghodoussipour
5 years
What a well deserved list of names! Feeling lucky to have learned from my former chief @isurujay, fellow @GU_BigWhacks, PD @GerhardFuchs9 and current partner @TomJangUroOnc
0
1
10
@SumeetBhanvadia
Sumeet Bhanvadia
5 years
Well of course!! And — you’re welcome @saumyg and @uro_nima
@saumyg
Saum Ghodoussipour
5 years
Practice-confirming data!
0
0
3
@neerajaiims
Neeraj Agarwal, MD, FASCO
5 years
#GU21 @ASCO Finally the phase 3 data on adjuvant nivolumab in @BladderCancerUS Trial met the primary endpoint of significantly improved disease free survival with @OncoAlert Hopefully approval soon @MattGalsky @urotoday
@neerajaiims
Neeraj Agarwal, MD, FASCO
5 years
#GU21 @ASCO is on the roll with many practice changing trials👉 Nivolumab is the new SOC in adjuvant Rx in #bladdercancer based on phase 3 Checkmate274 data with 10 mo delay in recurrence 👇 @MattGalsky @IcahnMountSinai #DeanBajorin https://t.co/Tl4DRsuohC @OncoAlert @urotoday
1
26
53
@neerajaiims
Neeraj Agarwal, MD, FASCO
5 years
Another very encouraging news in pre-print👉 Recent mutation (N501Y) in #COVID19 which makes it spread faster does not affect the efficacy of Covid-19 vaccine from Pfizer and BioNTech.👇Weblink: https://t.co/SZlMkWXfO6 @OncoAlert
1
23
49
@JohnsHopkins
Johns Hopkins University
5 years
The best way to support #healthcare workers right now is to avoid adding to their workload. Keep yourself and others healthy by wearing a mask and avoiding gatherings.
Tweet card summary image
hub.jhu.edu
The pandemic is at its worst, but there are still opportunities to show appreciation for those on the frontlines of health care delivery
2
47
104